Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The STEP UP trial, a Phase 3b study published in The Lancet Diabetes & Endocrinology in 2025, evaluated a 7.2 mg weekly injection dose in over 1,400 adults with obesity (BMI of 30 or higher) and without diabetes
Weight loss in the first week on GLP-1 therapy like semaglutide or tirzepatide is typically minimal to nonexistent for most patients
Although a decrease in systolic blood pressure is observed with GLP-1 RAs (ranging from 1.84 mmHg [95% CI 3.48 to 0.20] to 4.60 mmHg [95% CI 7.18 to 2.03]) [113], the possibility of requiring adjustment of simultaneous diuretic treatment should be considered
(2020) Ferroptosis and its potential role in human diseases, Front
Activating these receptors may lead to an apparent increase in growth hormone synthesis, and some researchers suggest that the simultaneous activation of the GHRH and ghrelin receptors on these pituitary cells may result in synergistically increased growth hormone elevation
The findings indicate that GLP-1 agonists may be an effective therapy to avoid severe liver disease in those with concurrent type 2 diabetes, according to the study authors
US$ 20.28
US$ 25.15
US$ 24.69
US$ 27.62
US$ 22.25
